IOSP Innospec Inc

Price (delayed)

$129.5

Market cap

$3.23B

P/E Ratio

21.88

Dividend/share

$1.48

EPS

$5.92

Enterprise value

$3B

Innospec Inc. is an international specialty chemicals company with approximately 1900 employees in 24 countries. Innospec manufactures and supplies a wide range of specialty chemicals to markets in the Americas, ...

Highlights
The quick ratio is up by 26% YoY and by 6% from the previous quarter
Innospec's net income has increased by 14% YoY and by 6% from the previous quarter
The stock's price to earnings (P/E) is 30% less than its 5-year quarterly average of 31.2 but 4.7% more than its last 4 quarters average of 20.9
Innospec's revenue has decreased by 3.1% YoY

Key stats

What are the main financial stats of IOSP
Market
Shares outstanding
24.93M
Market cap
$3.23B
Enterprise value
$3B
Valuations
Price to book (P/B)
2.72
Price to sales (P/S)
1.66
EV/EBIT
16.43
EV/EBITDA
13.46
EV/Sales
1.55
Earnings
Revenue
$1.94B
EBIT
$182.7M
EBITDA
$223.1M
Free cash flow
$196.7M
Per share
EPS
$5.92
Free cash flow per share
$7.9
Book value per share
$47.6
Revenue per share
$77.91
TBVPS
$51.32
Balance sheet
Total assets
$1.73B
Total liabilities
$546.6M
Debt
$43.6M
Equity
$1.18B
Working capital
$548M
Liquidity
Debt to equity
0.04
Current ratio
2.5
Quick ratio
1.61
Net debt/EBITDA
-1.02
Margins
EBITDA margin
11.5%
Gross margin
30.9%
Net margin
7.6%
Operating margin
8.9%
Efficiency
Return on assets
8.8%
Return on equity
13%
Return on invested capital
25.8%
Return on capital employed
13.4%
Return on sales
9.4%
Dividend
Dividend yield
1.14%
DPS
$1.48
Payout ratio
25%

IOSP stock price

How has the Innospec stock price performed over time
Intraday
-0.64%
1 week
-1.31%
1 month
7.45%
1 year
32.28%
YTD
5.08%
QTD
0.43%

Financial performance

How have Innospec's revenue and profit performed over time
Revenue
$1.94B
Gross profit
$599M
Operating income
$171.9M
Net income
$147.3M
Gross margin
30.9%
Net margin
7.6%
The net margin rose by 17% year-on-year and by 7% since the previous quarter
Innospec's net income has increased by 14% YoY and by 6% from the previous quarter
The operating margin has increased by 7% since the previous quarter but it has declined by 3.3% year-on-year
The company's operating income fell by 7% YoY but it rose by 6% QoQ

Growth

What is Innospec's growth rate over time

Valuation

What is Innospec stock price valuation
P/E
21.88
P/B
2.72
P/S
1.66
EV/EBIT
16.43
EV/EBITDA
13.46
EV/Sales
1.55
The stock's price to earnings (P/E) is 30% less than its 5-year quarterly average of 31.2 but 4.7% more than its last 4 quarters average of 20.9
The company's EPS rose by 13% YoY and by 6% QoQ
The P/B is 18% more than the 5-year quarterly average of 2.3 and 9% more than the last 4 quarters average of 2.5
The equity is up by 10% YoY and by 3.2% from the previous quarter
The price to sales (P/S) is 19% higher than the last 4 quarters average of 1.4 and 11% higher than the 5-year quarterly average of 1.5
Innospec's revenue has decreased by 3.1% YoY

Efficiency

How efficient is Innospec business performance
IOSP's ROA is up by 11% year-on-year and by 3.5% since the previous quarter
IOSP's return on invested capital is up by 10% year-on-year and by 8% since the previous quarter
The company's return on sales rose by 7% QoQ and by 3.3% YoY
Innospec's ROE has increased by 7% YoY and by 4% from the previous quarter

Dividends

What is IOSP's dividend history
DPS
$1.48
Dividend yield
1.14%
Payout ratio
25%
Recent dividends

Financial health

How did Innospec financials performed over time
The quick ratio is up by 26% YoY and by 6% from the previous quarter
The current ratio has grown by 9% YoY and by 5% from the previous quarter
The debt is 96% smaller than the equity
Innospec's debt to equity has decreased by 20% YoY
The debt has declined by 11% year-on-year and by 3.5% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.